Novavax’ ResVax flops in late-stage study
A late-stage study of Novavax’ respiratory syncytial virus vaccine ResVax has failed to hit its main goal.
Read More
A late-stage study of Novavax’ respiratory syncytial virus vaccine ResVax has failed to hit its main goal.
Read More
